Ebeling, M.C.; Geng, Z.; Stahl, M.R.; Kapphahn, R.J.; Roehrich, H.; Montezuma, S.R.; Ferrington, D.A.; Dutton, J.R.
Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration. Pharmaceuticals 2022, 15, 62.
https://doi.org/10.3390/ph15010062
AMA Style
Ebeling MC, Geng Z, Stahl MR, Kapphahn RJ, Roehrich H, Montezuma SR, Ferrington DA, Dutton JR.
Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration. Pharmaceuticals. 2022; 15(1):62.
https://doi.org/10.3390/ph15010062
Chicago/Turabian Style
Ebeling, Mara C., Zhaohui Geng, Madilyn R. Stahl, Rebecca J. Kapphahn, Heidi Roehrich, Sandra R. Montezuma, Deborah A. Ferrington, and James R. Dutton.
2022. "Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration" Pharmaceuticals 15, no. 1: 62.
https://doi.org/10.3390/ph15010062
APA Style
Ebeling, M. C., Geng, Z., Stahl, M. R., Kapphahn, R. J., Roehrich, H., Montezuma, S. R., Ferrington, D. A., & Dutton, J. R.
(2022). Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration. Pharmaceuticals, 15(1), 62.
https://doi.org/10.3390/ph15010062